<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Atrial arrhythmias (including AV block) in congenital heart disease</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Atrial arrhythmias (including AV block) in congenital heart disease</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Atrial arrhythmias (including AV block) in congenital heart disease</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Samuel Asirvatham, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Heidi M Connolly, MD, FACC, FASE</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Christopher J McLeod, MB, ChB, PhD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Hugh Calkins, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Charles I Berul, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Susan B Yeon, MD, JD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 08, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H181202946"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>One of the striking successes in caring for patients with congenital heart disease (CHD) over the last few decades is the improved longevity. Over one million adults with CHD are now living in the United States [<a href="#rid1">1-4</a>]; up to half having undergone at least one open heart surgical procedure resulting in one or more residual atrial scars [<a href="#rid5">5,6</a>]. For the purposes of this topic, CHD does not include bicuspid valves.</p><p>As a consequence of both the added longevity and the atrial scarring from surgical procedures, atrial arrhythmias are increasingly recognized in this group. They are a major cause of hospital admission and morbidity in patients with CHD [<a href="#rid7">7-9</a>]. These rhythm abnormalities may be poorly tolerated and are associated with an almost 50 percent increase in mortality compared with those patients without atrial arrhythmias [<a href="#rid9">9</a>].</p><p>Although all forms of atrial bradycardia and tachycardia can adversely affect patients with CHD, there are particular considerations in this group because of the anatomy and prior surgical repairs. Although some arrhythmias are intrinsic to the cardiac maldevelopment itself, most are secondary to surgical scars and chronic hemodynamic burden.</p><p>This review will focus on the management of these arrhythmias  (<a class="graphic graphic_table graphicRef64292" href="/d/graphic/64292.html" rel="external">table 1</a>), which should involve a comprehensive multidisciplinary approach.</p><p class="headingAnchor" id="H181202953"><span class="h1">PREVALENCE AND INCIDENCE</span><span class="headingEndMark"> — </span>Excluding bicuspid aortic valve, around 1 percent of infants are born with congenital heart disease (CHD)  (<a class="graphic graphic_table graphicRef78627" href="/d/graphic/78627.html" rel="external">table 2</a>), with minor reported racial differences in the United States [<a href="#rid10">10</a>]. Many of the congenital cardiac lesions (45 percent) are classified as simple forms, such as atrial septal defects (ASD) and ventricular septal defects (VSD); moderate forms of CHD such as tetralogy of Fallot occur less commonly, and complex CHD occurs infrequently [<a href="#rid11">11</a>]. The epidemiology of CHD is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/5774.html" rel="external">"Identifying newborns with critical congenital heart disease", section on 'Epidemiology'</a>.)</p><p>The abnormal hemodynamics associated with CHD (through atrial stretch and concomitant fibrosis) exaggerates an arrhythmogenic milieu and increases the likelihood of atrial arrhythmias over time. (See  <a class="medical medical_review" href="/d/html/5754.html" rel="external">"Isolated atrial septal defects (ASDs) in children: Classification, clinical features, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/5779.html" rel="external">"Isolated atrial septal defects (ASDs) in children: Management and outcome"</a> and  <a class="medical medical_review" href="/d/html/5770.html" rel="external">"Tetralogy of Fallot (TOF): Management and outcome"</a> and  <a class="medical medical_review" href="/d/html/5769.html" rel="external">"Tetralogy of Fallot (TOF): Pathophysiology, clinical features, and diagnosis"</a>.)</p><p>Longitudinal studies suggest that atrial tachyarrhythmias afflict between 20 and 50 percent of individuals with CHD over their lifetime [<a href="#rid9">9</a>]. Approximately half of patients who have ASD repair over age 25 years [<a href="#rid12">12</a>] and nearly one-third of patients with tetralogy of Fallot develop atrial tachyarrhythmias [<a href="#rid13">13</a>]. (See  <a class="medical medical_review" href="/d/html/1418.html" rel="external">"Clinical manifestations and diagnosis of atrial septal defects in adults"</a> and  <a class="medical medical_review" href="/d/html/1092.html" rel="external">"Atrial septal abnormalities (PFO, ASD, and ASA) and risk of cerebral emboli in adults"</a> and  <a class="medical medical_review" href="/d/html/1100.html" rel="external">"Stroke associated with patent foramen ovale (PFO): Evaluation"</a>.)</p><p>The development of atrial tachyarrhythmias is associated with higher morbidity, mortality, and hospitalization rates in patients with CHD and a worse functional class. Atrial tachyarrhythmias are independently associated with a higher risk of death in patients with single-ventricle anatomy, pulmonary hypertension, and valvular heart disease [<a href="#rid14">14</a>].</p><p>Atrial arrhythmias are seen in more than half of patients with the more complex repairs such as the classical atriopulmonary Fontan operation [<a href="#rid15">15,16</a>], and in response to this, alternate surgical approaches such as the extracardiac Fontan, which excludes the right atrium and the nidus for atrial arrhythmias, have evolved [<a href="#rid17">17,18</a>].</p><p>The frequency of congenital heart disease as a cause of atrial arrhythmias in the fetal heart is discussed separately. (See  <a class="medical medical_review" href="/d/html/6765.html" rel="external">"Fetal arrhythmias"</a>.)</p><p class="headingAnchor" id="H181202960"><span class="h1">PATHOPHYSIOLOGY</span><span class="headingEndMark"> — </span>Tachycardias in this group of patients most commonly have a reentrant mechanism and are facilitated by abnormal atrial substrate adjacent to valves, patches, or suture lines. In addition, cellular injury from longstanding hypoxia and atrial stretch conceivably also engenders inhomogeneity in myocardial conduction and refractoriness and hence adds to the arrhythmogenic milieu  (<a class="graphic graphic_table graphicRef64292" href="/d/graphic/64292.html" rel="external">table 1</a>) [<a href="#rid19">19</a>]. (See  <a class="medical medical_review" href="/d/html/6435.html" rel="external">"Approach to the child with tachycardia"</a>.)</p><p>Bradycardia can be inherent to the congenital anomaly, such as abnormalities of the sinus node or atrioventricular (AV) node in the heterotaxy (isomerism) syndromes, L-transposition of great arteries, or AV septal defects [<a href="#rid20">20,21</a>]. However, bradycardia is most commonly seen secondary to iatrogenic disruption of these structures and can occur in both the early postoperative period and/or many years after the operation, presumably driven by fibrosis [<a href="#rid15">15,22-25</a>]  (<a class="graphic graphic_table graphicRef64292" href="/d/graphic/64292.html" rel="external">table 1</a>). (See  <a class="medical medical_review" href="/d/html/5759.html" rel="external">"Bradycardia in children"</a>.)</p><p class="headingAnchor" id="H181202968"><span class="h2">Bradycardias</span><span class="headingEndMark"> — </span>Symptomatic bradycardia can cause considerable morbidity in patients with congenital heart disease (CHD). Pacemaker implantation is required for bradyarrhythmias in up to 3 to 4 percent of patients after surgical repair of Ebstein anomaly [<a href="#rid26">26</a>]; in approximately 7 percent of Fontan patients [<a href="#rid15">15,27</a>]; in over 80 percent of patients who have undergone atrial switch procedures for d-transposition of the great arteries; and around half of those patients with congenitally corrected transposition [<a href="#rid28">28</a>] of the great arteries (ccTGA) [<a href="#rid22">22</a>]. (See  <a class="medical medical_review" href="/d/html/8146.html" rel="external">"Ebstein anomaly: Clinical manifestations and diagnosis"</a>.)</p><p class="headingAnchor" id="H181202976"><span class="h3">Congenital sinus node dysfunction</span><span class="headingEndMark"> — </span>Superior sinus venosus ASDs (occurring in the septum between the superior vena cava and right-sided pulmonary veins) account for around 5 to 10 percent of all ASDs [<a href="#rid29">29,30</a>]. Due to the location of this defect, congenital sinus node dysfunction is commonly found [<a href="#rid31">31</a>]. This is also the case in the other rare CHD lesions that involve the heterotaxy syndromes or juxtaposed atrial appendages [<a href="#rid32">32</a>]. (See  <a class="medical medical_review" href="/d/html/1418.html" rel="external">"Clinical manifestations and diagnosis of atrial septal defects in adults", section on 'Sinus venosus defect'</a> and  <a class="medical medical_review" href="/d/html/6765.html" rel="external">"Fetal arrhythmias"</a>.)</p><p class="headingAnchor" id="H604936099"><span class="h3">Acquired sinus node dysfunction</span><span class="headingEndMark"> — </span>Any procedure involving an atriotomy such as cannulation for cardiopulmonary bypass potentially risks injury to the sinus node by virtue of its location. More extensive congenital operations involving atrial repair pose substantial risk to the sinus node. These include the atrial switch (Mustard/Senning), Glenn, Fontan, and Ebstein repairs [<a href="#rid15">15,22,23,33</a>]. Patients may present with an overt loss of sinus rhythm or a poor chronotropic response to exercise [<a href="#rid22">22,23</a>]. (See  <a class="medical medical_review" href="/d/html/95232.html" rel="external">"Management of complications in patients with Fontan circulation", section on 'Arrhythmias'</a>.)</p><p class="headingAnchor" id="H181202983"><span class="h3">Congenital AV block</span><span class="headingEndMark"> — </span>While familial congenital AV block is reported, the majority of congenital AV block is secondary to maternal auto-antibodies in the settings of diseases like systemic lupus erythematosus and Sjögren's disease [<a href="#rid34">34,35</a>]. The AV node is a right atrial structure, whereas the His bundle, the electrical continuation of the AV node, is a ventricular structure. Therefore, anatomical defects, which include misalignment of these two contiguous chambers, frequently result in interruption of AV conduction. These anomalies include ccTGA, large primum ASDs, and large AV septal defects (AV canal defects) [<a href="#rid21">21,36</a>]. These malformations can result in either complete heart block or progressive AV conduction disease [<a href="#rid37">37</a>]. (See  <a class="medical medical_review" href="/d/html/1415.html" rel="external">"Pregnancy in women with congenital heart disease: Specific lesions", section on 'Congenitally corrected transposition of the great arteries'</a> and  <a class="medical medical_review" href="/d/html/86278.html" rel="external">"Management and outcome of atrioventricular (AV) canal defects", section on 'Arrhythmias'</a>.)</p><p class="headingAnchor" id="H181202997"><span class="h3">Acquired AV node dysfunction</span><span class="headingEndMark"> — </span>Surgical trauma in the region of the AV conduction axis occurs most commonly with operations that involve this region, such as aortic valve, left ventricular outflow tract, or AV valve repair/replacement [<a href="#rid24">24</a>].</p><p class="headingAnchor" id="H181203004"><span class="h2">Tachycardias</span></p><p class="headingAnchor" id="H181203019"><span class="h3">Intraatrial reentrant tachycardia</span><span class="headingEndMark"> — </span>Atrial scars in repaired CHD patients provide a fundamental element for the development of intraatrial reentrant tachycardia (IART), which is the most common atrial tachyarrhythmia [<a href="#rid33">33</a>] in this population (see  <a class="medical medical_review" href="/d/html/937.html" rel="external">"Intraatrial reentrant tachycardia"</a>). Mechanistically, IART is similar to atrial flutter, with a macro-reentrant circuit requiring a zone of slow conduction that develops in diseased tissue and is bordered by scars/valve or vena cava.</p><p>Found primarily in patients where the atrial tissue is damaged through chronic stretch or operative scars, these circuits usually develop many years after the original intervention [<a href="#rid38">38,39</a>]. Classical intracardiac Fontan repairs, which utilize atrial tissue and the Mustard/Senning procedures, are most commonly associated with this arrhythmia. They can occur also with simple atriotomy scars  (<a class="graphic graphic_figure graphicRef75779" href="/d/graphic/75779.html" rel="external">figure 1</a>). Concomitant sinus node dysfunction and older age at first surgical repair appear to increase the incidence [<a href="#rid15">15</a>]. The atrial rate may vary between 150 and 250 beats per minute, and in the presence of preserved AV nodal function, the ensuing ventricular response may be 1:1, with rapid clinical deterioration.</p><p class="headingAnchor" id="H181203026"><span class="h3">Atrial fibrillation</span><span class="headingEndMark"> — </span>The pulmonary venous origins of paroxysmal atrial fibrillation in CHD do not appear to differ markedly from acquired heart disease [<a href="#rid40">40</a>]. Left heart lesions with subsequent left atrial stretch and fibrosis are most commonly associated with this rhythm abnormality. Associated coronary disease or lesions involving the left ventricular outflow tract and/or mitral valve are the more commonly related lesions [<a href="#rid41">41</a>]. The presence of CHD does not preclude other conditions contributing to atrial arrhythmias such as obstructive sleep apnea and thyroid disease, and these should be sought.</p><p class="headingAnchor" id="H181203033"><span class="h3">Ectopic/focal atrial tachycardia</span><span class="headingEndMark"> — </span>The precise etiology and prevalence of this arrhythmia in CHD is less clear (see  <a class="medical medical_review" href="/d/html/900.html" rel="external">"Focal atrial tachycardia"</a>). It is far less common than IART and appears to be more prevalent in children than in adults with CHD [<a href="#rid42">42</a>]. It may originate from atrial tissue within the Fontan circuit, from the atrial appendages, or adjacent to the pulmonary veins. On the surface electrocardiogram, this arrhythmia can be identified by the unusual p-wave axis and often a progressive increase in the rate. Catheter ablation of the focus, however, is associated with much higher rates of success than IART and provides an excellent chance of cure [<a href="#rid43">43</a>].</p><p class="headingAnchor" id="H181203047"><span class="h1">EVALUATION</span></p><p class="headingAnchor" id="H181203055"><span class="h2">Cardiac referral and further evaluation</span><span class="headingEndMark"> — </span>The management and treatment of patients with congenital heart disease (CHD) and atrial arrhythmias are often more complex than more typical arrhythmia patients. These patients should be referred to centers that routinely follow this population [<a href="#rid44">44-46</a>]. Importantly, atrial arrhythmias can be a harbinger of underlying hemodynamic deterioration, and a comprehensive congenital clinical and hemodynamic assessment is vital for all congenital cardiac patients.</p><p class="headingAnchor" id="H181203063"><span class="h2">History</span><span class="headingEndMark"> — </span>A thorough surgical history, including operative reports, is necessary. This information is critical not only in the diagnostic work-up of the patient and atrial arrhythmia, but also in identifying whether venous access for catheters or permanent pacing is feasible. Similarly, during pacing or ablation procedures, inadvertent injury to the AV conduction system may occur. In these instances, it is critical to know whether a transvenous route to rapidly pace the ventricle is available.</p><p class="headingAnchor" id="H181203071"><span class="h2">Physical examination</span><span class="headingEndMark"> — </span>The physical examination is important in order to identify evidence for concomitant cardiovascular lesions, which may be integral to the arrhythmia development. For example, the presence of peripheral edema, ascites, and an enlarged liver might identify Fontan obstruction or failure, and revision of this conduit may prove to be the most appropriate ultimate intervention for worsening atrial arrhythmias.</p><p class="headingAnchor" id="H181203079"><span class="h2">Electrocardiogram</span><span class="headingEndMark"> — </span>The 12-lead electrocardiogram (ECG) is instrumental in clarifying the underlying rhythm disturbance in CHD patients [<a href="#rid47">47</a>]. However, the ECG can be misleading in this patient population, reemphasizing the importance of specialty care  (<a class="graphic graphic_waveform graphicRef114371" href="/d/graphic/114371.html" rel="external">waveform 1</a>). Patients with intraatrial reentrant tachycardia (IART) often have atrial rates that are slower than typical cavotricuspid isthmus dependent flutter, with discrete p-waves and an isoelectric interval. This rhythm is often mistaken for sinus tachycardia, as the p-wave can be buried in the preceding QRS complex or in the setting of 1:1 conduction through a healthy AV node  (<a class="graphic graphic_waveform graphicRef52478" href="/d/graphic/52478.html" rel="external">waveform 2</a>). Patients who have undergone modified Maze surgeries often have very little evidence of atrial activity on the ECG, making electrocardiographic diagnosis challenging [<a href="#rid48">48</a>]. (See  <a class="medical medical_review" href="/d/html/1046.html" rel="external">"Atrial fibrillation: Surgical ablation"</a> and  <a class="medical medical_review" href="/d/html/1046.html" rel="external">"Atrial fibrillation: Surgical ablation", section on 'Maze procedure'</a>.)</p><p>An underlying IART may be missed in this instance and running a longer rhythm strip can be helpful to identify grouped beating occurring in the context of variable AV block. The T wave should also be scrutinized for any sharp deflections not usually associated with repolarization, and hence indicative of atrial depolarization.</p><p class="headingAnchor" id="H181203087"><span class="h2">Echocardiogram</span><span class="headingEndMark"> — </span>The transthoracic echocardiogram is invaluable in identifying structural and hemodynamic cardiac lesions that may have precipitated the rhythm disturbance. Conduit or valvular dysfunction may lead to secondary effects on the atrial muscle and thus a CHD specialist should interpret the echocardiograms in these patients. The echo examination may also provide the first clue to an atrial rhythm disturbance or demonstrate reduction in ventricular function from tachycardia. Fetal echocardiography has allowed identification of congenital cardiac anomalies, and this should be considered in fetuses at increased risk. (See  <a class="medical medical_review" href="/d/html/6755.html" rel="external">"Congenital heart disease: Prenatal screening, diagnosis, and management"</a>.)</p><p class="headingAnchor" id="H181203095"><span class="h2">Ambulatory ECG/Holter monitoring/prolonged cardiac monitoring device</span><span class="headingEndMark"> — </span>Twenty-four-hour Holter recordings or prolonged device monitoring (such as wireless patch cardiac monitors) are important tools to identify the underlying rhythm abnormality when the patient's ECG is unrevealing and there is a history of presyncope, syncope, or palpitations [<a href="#rid49">49</a>]. In addition, this can be a useful adjunctive investigation when chronotropic incompetence is suspected, due to underlying sinus, AV node, or medication-related bradycardia. (See  <a class="medical medical_review" href="/d/html/958.html" rel="external">"Ambulatory ECG monitoring"</a>.)</p><p class="headingAnchor" id="H181203103"><span class="h2">Event monitor</span><span class="headingEndMark"> — </span>The event monitor is used to identify the etiology of short-lived symptoms that cannot be characterized by the ECG, Holter recordings, or prolonged device monitoring. One- to three-month periods of transient cardiac event monitors or looping recorders are frequently employed diagnostically, and insertable cardiac monitors (ICM; also sometimes referred to as implantable cardiac monitor or implantable loop recorder) can be considered for patients with infrequent symptoms. (See  <a class="medical medical_review" href="/d/html/958.html" rel="external">"Ambulatory ECG monitoring"</a>.)</p><p class="headingAnchor" id="H181203111"><span class="h2">Exercise testing</span><span class="headingEndMark"> — </span>Exercise testing is vital in demonstrating chronotropic incompetence in the setting of symptomatic sinus node dysfunction and also for exposing infranodal AV conduction block in those patients with 2:1 AV block or exertional dyspnea. Catecholaminergic surges that develop during maximal effort can also precipitate tachyarrhythmias by influencing conduction velocity and refractoriness. In addition, faster AV node function during exercise may allow 1:1 conduction in the context of a previously undiagnosed atrial tachycardia with 2:1 AV block. (See  <a class="medical medical_review" href="/d/html/1494.html" rel="external">"Exercise ECG testing: Performing the test and interpreting the ECG results"</a>.)</p><p class="headingAnchor" id="H181203119"><span class="h2">Electrophysiology study</span><span class="headingEndMark"> — </span>It is recommended to proceed with an electrophysiology study in the evaluation of the patient with CHD following an unexplained cardiac arrest or syncopal event, and for those who present with sustained ventricular tachycardia. This is aimed at identifying potential lethal sinus or AV nodal disease and can identify whether a ventricular arrhythmia was likely causative. Electrophysiology study is also recommended in select CHD patients prior to cardiac surgical intervention such as those with Ebstein anomaly with a history of arrhythmias [<a href="#rid50">50</a>]. It should also be considered for this group of patients with palpitations where a standard workup has been unrevealing [<a href="#rid50">50</a>]. (See  <a class="medical medical_review" href="/d/html/980.html" rel="external">"Invasive diagnostic cardiac electrophysiology studies"</a>.)</p><p class="headingAnchor" id="H181203127"><span class="h1">MANAGEMENT</span><span class="headingEndMark"> — </span>It is important to recognize that in the management of atrial tachyarrhythmias in patients with congenital heart disease (CHD), rhythm versus rate control has not been studied. (See  <a class="medical medical_review" href="/d/html/1045.html" rel="external">"Management of atrial fibrillation: Rhythm control versus rate control"</a>.) The AFFIRM and HOT-CAFÉ studies [<a href="#rid51">51,52</a>] did not include patients with CHD with or without prior repair, and as such we do not have any long-term data comparing the outcomes with these strategies. In addition, the most common atrial arrhythmia encountered in clinical practice is that of intraatrial reentrant tachycardia [<a href="#rid41">41</a>], an arrhythmia that is unlikely to respond to rate-control because of the fixed circuit and slower atrial cycle length. For this reason, antiarrhythmic medications and ablation provide the cornerstone of therapy [<a href="#rid50">50</a>].</p><p class="headingAnchor" id="H181203135"><span class="h2">Acute termination</span><span class="headingEndMark"> — </span>For any atrial tachyarrhythmia that is associated with hemodynamic instability, synchronized direct current (DC) cardioversion should be utilized without delay. (See  <a class="medical medical_review" href="/d/html/975.html" rel="external">"Basic principles and technique of external electrical cardioversion and defibrillation"</a>.)</p><p>DC cardioversion can also be reserved for the initial management of hemodynamically stable yet symptomatic arrhythmias if a more definitive strategy has not yet been chosen, and the patient has fairly infrequent episodes. In this context, transesophageal echocardiography (TEE) to identify intracardiac clot is strongly recommended, especially in Fontan circulations, irrespective of the anticoagulation status [<a href="#rid53">53,54</a>]. The classical Fontan often entails sluggish blood flow, and atrial thrombus formation is common. Embolism of the thrombus into the pulmonary bed through DC cardioversion can be fatal in these patients. Cardioversion in the patient with CHD with appropriate precautions including anticoagulation and pre- or periprocedure TEE is proven to be safe and effective and should not be withheld [<a href="#rid54">54,55</a>]. TEE-guided cardioversions for Fontan and other high-risk congenital patients are commonly done in conjunction with anesthesia staff due to tenuous hemodynamics and the risk of complications related to sedation.</p><p>Symptomatic bradyarrhythmias may require acute temporary pacing, and preprocedure knowledge of intracardiac and vena caval anatomy is critical. Anticoagulation is recommended for any CHD patient with an intracardiac shunt receiving a temporary pacemaker to avoid systemic thromboembolism from the pacing lead, until a permanent epicardial or alternate percutaneous system can be placed. (See  <a class="medical medical_review" href="/d/html/1005.html" rel="external">"Temporary cardiac pacing"</a>.)</p><p class="headingAnchor" id="H181203142"><span class="h2">Permanent pacemaker implantation</span><span class="headingEndMark"> — </span>In general, the indications for permanent pacing in CHD are similar to those in acquired heart disease. All symptomatic sinus or AV node disease requires pacemaker intervention [<a href="#rid56">56</a>]. (See  <a class="medical medical_review" href="/d/html/941.html" rel="external">"Permanent cardiac pacing: Overview of devices and indications"</a> and  <a class="medical medical_review" href="/d/html/912.html" rel="external">"Congenital third-degree (complete) atrioventricular block"</a>.)</p><p>Several special considerations apply to patients with CHD who require pacemaker implantation:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Planning of lead access</strong> – Lead access frequently poses difficulties in this group, and a detailed surgical history is necessary, often with adjunctive review of cross-sectional imaging (eg, computerized tomography, magnetic resonance imaging) or venography. In complex CHD patients with prior operative intervention in whom surgical reports are not available and urgent pacemaker placement is needed, imaging of venous anatomy with cross-sectional imaging or venography is crucial.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Avoid thromboembolic stroke</strong> – To avoid paradoxical thromboembolic stroke from transvenous lead thrombus, the clinician should image the heart and vessels (TEE with bubble study or venography) to exclude intracardiac shunting/baffle-leaks. If these are present and not amenable to closure, epicardial pacemaker lead placement may be indicated, depending on the patient-specific comorbid conditions [<a href="#rid57">57-59</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>No lead across mechanical tricuspid valve</strong> – In patients with a mechanical tricuspid (non-systemic AV) valve, a pacemaker lead should not be positioned crossing the valve. Options in this setting include a coronary sinus lead [<a href="#rid60">60</a>] or an epicardial lead.</p><p></p><p class="headingAnchor" id="H181203150"><span class="h2">Antiarrhythmic drug therapy</span><span class="headingEndMark"> — </span>Antiarrhythmic drugs remain a cornerstone in the management of atrial arrhythmias in CHD patients. Class I agents (such as <a class="drug drug_general" data-topicid="9821" href="/d/drug information/9821.html" rel="external">propafenone</a> or <a class="drug drug_general" data-topicid="8449" href="/d/drug information/8449.html" rel="external">flecainide</a>) should be avoided in any patient with ventricular scar given the potential for life-threatening ventricular arrhythmias [<a href="#rid61">61-63</a>]. (See  <a class="medical medical_review" href="/d/html/961.html" rel="external">"Arrhythmia management for the primary care clinician"</a>.) These medications slow cardiac electrical conduction, can also result in slower, more sustained atrial flutters, and hence are not the medications of choice in this group. <a class="drug drug_general" data-topicid="8904" href="/d/drug information/8904.html" rel="external">Dofetilide</a> [<a href="#rid64">64</a>] and <a class="drug drug_general" data-topicid="9941" href="/d/drug information/9941.html" rel="external">sotalol</a> [<a href="#rid65">65</a>] delay repolarization and therefore are the most suitable for reentrant atrial arrhythmias (such as intraatrial reentrant tachycardia), with dofetilide having the added benefit of avoiding any impact on the sinus or AV nodes in the bradycardic patient [<a href="#rid66">66</a>]. (See  <a class="medical medical_review" href="/d/html/925.html" rel="external">"Clinical uses of sotalol"</a> and  <a class="medical medical_review" href="/d/html/1033.html" rel="external">"Clinical use of dofetilide"</a>.)</p><p>The most effective drug is <a class="drug drug_general" data-topicid="8595" href="/d/drug information/8595.html" rel="external">amiodarone</a> [<a href="#rid67">67</a>], although significant side effects may be problematic leading to noncompliance or discontinuation [<a href="#rid68">68</a>]. (See  <a class="medical medical_review" href="/d/html/931.html" rel="external">"Amiodarone: Adverse effects, potential toxicities, and approach to monitoring"</a> and  <a class="medical medical_review" href="/d/html/926.html" rel="external">"Amiodarone: Clinical uses"</a>.) Long-term use of amiodarone requires close monitoring of eye, thyroid, pulmonary, and hepatic function [<a href="#rid64">64</a>], and this should rarely be considered as lifelong suppressive therapy in the younger adult CHD patient with atrial arrhythmias [<a href="#rid50">50</a>].</p><p class="headingAnchor" id="H181203157"><span class="h2">Ablation</span><span class="headingEndMark"> — </span>Radiofrequency catheter ablation (RFA) is now utilized early in the course of many adult congenital patients with atrial tachyarrhythmias. Atrial arrhythmia ablation should be considered in symptomatic patients refractory to or unsuitable for long-term antiarrhythmic therapy. Minimally symptomatic atrial tachyarrhythmias can also be targeted with this approach to avoid a tachycardia-mediated decline in ventricular function.</p><p>RFA can be complex in patients with CHD, and it is recommended these procedures be performed at centers experienced with RFA in this patient population [<a href="#rid50">50</a>].<strong> </strong>Although early success rates are excellent even in the most complex defects [<a href="#rid69">69,70</a>], long-term recurrence rates remain suboptimal, especially when multiple circuits coexist and atrial scars are abundant [<a href="#rid71">71</a>]. The clinical tachycardia can most often be eradicated to reduce symptomatic recurrence and improve antiarrhythmic drug therapy or pacing efficacy [<a href="#rid72">72-74</a>], yet other arrhythmias can subsequently develop. Older age at time of ablation and complexity of the atrial repair (Fontan or atrial-switch) both predict worse procedural success [<a href="#rid75">75</a>]. It is also important to recognize that the electrophysiological study often unmasks underlying sinus node dysfunction, and a role for permanent pacing may be identified [<a href="#rid75">75</a>]. For this reason, we recommend discussing this antecedently with patients.</p><p class="headingAnchor" id="H181203164"><span class="h2">Atrial antitachycardia devices</span><span class="headingEndMark"> — </span>Pacemakers with atrial antitachycardia pacing capability have been used to treat reentrant atrial tachycardias in patients with CHD. As a sole therapy, long-term efficacy for this approach is poor, but can be considered in patients with symptomatic bradycardia and/or other clear indications for pacing. In this setting, and often in conjunction with ablation, Maze, or anti-arrhythmic drug therapy, this pacing strategy can be effective in limiting symptomatic exacerbations [<a href="#rid76">76,77</a>].</p><p class="headingAnchor" id="H181203171"><span class="h2">Maze surgery</span><span class="headingEndMark"> — </span>CHD patients undergoing operative repair of a cardiac defect should be considered for Maze surgery if there is a background of atrial arrhythmias [<a href="#rid78">78</a>]. Cut-and-sew techniques have higher rates of freedom from atrial arrhythmia when compared with alternative energy sources such as radio-frequency ablation or cryoablation [<a href="#rid79">79,80</a>]. No data currently exist on preemptive Maze surgery in CHD patients at high risk for, but without, prior documented arrhythmias. (See  <a class="medical medical_review" href="/d/html/1046.html" rel="external">"Atrial fibrillation: Surgical ablation"</a> and  <a class="medical medical_review" href="/d/html/1046.html" rel="external">"Atrial fibrillation: Surgical ablation", section on 'Maze procedure'</a>.)</p><p class="headingAnchor" id="H181203179"><span class="h2">Anticoagulation therapy</span><span class="headingEndMark"> — </span>Anticoagulation therapy should be considered in CHD patients as soon as an atrial rhythm disturbance is identified.</p><p>Patients with Fontan circulations have low flow states [<a href="#rid81">81</a>] and are at high risk of thrombus formation within the atria or Fontan circuit. Patients with repaired atrial septal defects also appear to be at high risk for thromboembolic complications in the setting of atrial arrhythmias, accounting for around one-fifth of late deaths in one series [<a href="#rid12">12</a>]. The use of conventional thromboembolic and hemorrhagic risk-assessment scores, such as CHA<sub>2</sub>DS<sub>2</sub>-VASc and CHADS2, has not been rigorously evaluated in these patient groups. National and international societal recommendations [<a href="#rid50">50</a>]<strong> </strong>do, however, recommend using the CHA<sub>2</sub>DS<sub>2</sub>-VASc risk schema for simple CHD syndromes (such as repaired atrial septal defect or ventricular septal defect) and then prescription of either <a class="drug drug_general" data-topicid="10050" href="/d/drug information/10050.html" rel="external">warfarin</a> or a direct oral anticoagulant is permissible. (See  <a class="medical medical_review" href="/d/html/1031.html" rel="external">"Atrial fibrillation in adults: Use of oral anticoagulants"</a> and  <a class="medical medical_review" href="/d/html/128998.html" rel="external">"Atrial fibrillation in adults: Selection of candidates for anticoagulation"</a>.)</p><p>For all other patients with atrial arrhythmias (those with CHD of moderate or severe complexity), <a class="drug drug_general" data-topicid="10050" href="/d/drug information/10050.html" rel="external">warfarin</a> is generally recommended without the need for thromboembolic risk stratification [<a href="#rid50">50</a>]. Limited data regarding the non-vitamin K oral anticoagulant agents suggest efficacy in CHD patients [<a href="#rid82">82-84</a>].</p><p class="headingAnchor" id="H181203193"><span class="h1">SPECIFIC CONSIDERATIONS</span></p><p class="headingAnchor" id="H181203209"><span class="h2">ASD</span><span class="headingEndMark"> — </span>Atrial septal defect (ASD) is one of the most common congenital cardiac anomalies and is associated with a high incidence of atrial arrhythmias, which increase in frequency as affected patients age [<a href="#rid9">9,12</a>]. (See  <a class="medical medical_review" href="/d/html/1417.html" rel="external">"Management of atrial septal defects in adults"</a>.)</p><p>The later in life the ASD is repaired, the more likely atrial arrhythmias are to develop. Surgical and device closure do not appear to mitigate the development of this problem [<a href="#rid12">12</a>]. In addition, significant thromboembolic complications have been observed in patients who had surgical ASD closure performed at 24 years of age or older, affecting around 22 percent of these patients [<a href="#rid12">12</a>]. For this reason, anticoagulation is recommended for all patients with atrial arrhythmias following surgical ASD closure with a CHA<sub>2</sub>DS<sub>2</sub>-VASc ≥2 [<a href="#rid50">50</a>].<strong> </strong>Atrial arrhythmias should be actively identified using routine ambulatory ECG monitoring. Intraatrial reentrant tachycardia circuits around a patch or suture lines also occur frequently, and ablative therapy should be considered early in their management [<a href="#rid85">85</a>].</p><p class="headingAnchor" id="H181203224"><span class="h2">Prior Maze</span><span class="headingEndMark"> — </span>Modified Maze operations are a common, safe, and highly effective surgical method of restoring sinus rhythm in patients with CHD and atrial fibrillation/flutter. (See  <a class="medical medical_review" href="/d/html/1046.html" rel="external">"Atrial fibrillation: Surgical ablation"</a>.)</p><p>These interventions, which are often performed at the time of CHD operations, can be effective in preventing atrial arrhythmia recurrence approximately 70 to 80 percent at 10 years [<a href="#rid86">86</a>].</p><p>Maze procedures present potential electrical and mechanical complications subsequent to the extensive transmural lesions that not only potentially interfere with sinus and intraatrial conduction but which can also disrupt atrial mechanical compliance and transport. Sinus node dysfunction, atrial bradyarrhythmias and tachyarrhythmias, and development of an indication for permanent pacemaker implantation are among the sequelae of the Maze procedure. New atrial tachyarrhythmias can develop around Maze lesions, and ablation of these is commonly subsequently necessary. Antiarrhythmic drug therapy is frequently used in this setting, and atrial antitachycardia pacemakers can be of added utility [<a href="#rid87">87</a>]. (See  <a class="medical medical_review" href="/d/html/1046.html" rel="external">"Atrial fibrillation: Surgical ablation", section on 'Limitations and complications'</a>.)</p><p class="headingAnchor" id="H181203239"><span class="h2">Tetralogy of Fallot</span><span class="headingEndMark"> — </span>Bradyarrhythmias requiring permanent pacing in patients with tetralogy of Fallot are uncommon. However, atrial tachyarrhythmias are a frequent cause of morbidity and may be seen in up to 25 percent of patients with tetralogy of Fallot [<a href="#rid13">13</a>] (see  <a class="medical medical_review" href="/d/html/5770.html" rel="external">"Tetralogy of Fallot (TOF): Management and outcome"</a>). The prevalence of atrial arrhythmias markedly increases after 45 years of age in this group and in those with reduced left ventricular function [<a href="#rid88">88</a>].</p><p class="headingAnchor" id="H181203246"><span class="h2">Fontan procedure</span><span class="headingEndMark"> — </span>The "classic" Fontan procedure that fashions an atriopulmonary conduit from right atrial tissue is more frequently associated with the development of atrial arrhythmias [<a href="#rid89">89</a>] compared with contemporary "extracardiac" Fontan procedures [<a href="#rid90">90</a>]. In a retrospective analysis of adult patients with prior Fontan procedure (mean follow-up of 18.6 years), 42 percent sustained at least one tachyarrhythmia [<a href="#rid74">74,91</a>]. The most common arrhythmia was intraatrial reentrant tachycardia. These are commonly recurrent issues and are associated with important morbidity [<a href="#rid70">70</a>]. Anticoagulation is recommended in all Fontan patients with atrial arrhythmias [<a href="#rid81">81</a>], and empiric anticoagulation is often recommended for all patients with the classical atriopulmonary connection, since these patients are at the highest risk of thromboembolic events and atrial arrhythmias [<a href="#rid90">90</a>].</p><p>Conversion to an extracardiac conduit or total cavopulmonary connection may provide hemodynamic relief and reduce the arrhythmia burden, but it comes with substantial inherent operative risk, and candidates for this procedure should be carefully selected [<a href="#rid92">92</a>].</p><p>Injury to the sinus node is also common following the Fontan procedure [<a href="#rid93">93</a>], and permanent pacing may be necessary.</p><p class="headingAnchor" id="H577561266"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/112260.html" rel="external">"Society guideline links: Arrhythmias in adults"</a>.)</p><p class="headingAnchor" id="H189979668"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, “The Basics” and “Beyond the Basics.” The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on “patient info” and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/d/html/17118.html" rel="external">"Patient education: Heart block in adults (The Basics)"</a> and  <a class="medical medical_basics" href="/d/html/83745.html" rel="external">"Patient education: Heart block in children (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H181203253"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Atrial arrhythmias are common in congenital heart disease (CHD), affecting at least 20 percent of CHD patients over their lifetime. (See <a class="local">'Prevalence and incidence'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Atrial arrhythmias are a major cause of morbidity in patients with CHD and can be precipitated by cardiac residua. They can also cause hemodynamic deterioration. For this reason, it is imperative that a comprehensive clinical and hemodynamic assessment be undertaken as part of the initial arrhythmia work-up. (See <a class="local">'Prevalence and incidence'</a> above and <a class="local">'Evaluation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>CHD patients with atrial arrhythmias should be referred to centers that routinely care for CHD patients.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bradycardia can be inherent to the CHD anomaly; however, it is more commonly seen secondary to operative disruption of the conduction system. This can occur in both the early postoperative period or later due to fibrosis. (See <a class="local">'Bradycardias'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Stroke is common in adult CHD patients, and atrial arrhythmias such as atrial fibrillation and intraatrial reentrant tachycardia (IART) should prompt the clinician to consider long-term oral anticoagulation. (See <a class="local">'Anticoagulation therapy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Indications for permanent pacing in CHD are similar to those in acquired heart disease. All symptomatic sinus or atrioventricular (AV) node disease requires pacemaker intervention with preemptive delineation of venous anatomy and intracardiac shunting being fundamental. (See <a class="local">'Permanent pacemaker implantation'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Marelli AJ, Mackie AS, Ionescu-Ittu R, et al. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation 2007; 115:163.</a></li><li><a class="nounderline abstract_t">Brickner ME, Hillis LD, Lange RA. Congenital heart disease in adults. Second of two parts. N Engl J Med 2000; 342:334.</a></li><li><a class="nounderline abstract_t">Brickner ME, Hillis LD, Lange RA. Congenital heart disease in adults. First of two parts. N Engl J Med 2000; 342:256.</a></li><li><a class="nounderline abstract_t">Gilboa SM, Devine OJ, Kucik JE, et al. Congenital Heart Defects in the United States: Estimating the Magnitude of the Affected Population in 2010. Circulation 2016; 134:101.</a></li><li><a class="nounderline abstract_t">Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002; 39:1890.</a></li><li><a class="nounderline abstract_t">Waldmann V, Laredo M, Abadir S, et al. Atrial fibrillation in adults with congenital heart disease. Int J Cardiol 2019; 287:148.</a></li><li><a class="nounderline abstract_t">Engelfriet P, Boersma E, Oechslin E, et al. The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. The Euro Heart Survey on adult congenital heart disease. Eur Heart J 2005; 26:2325.</a></li><li><a class="nounderline abstract_t">Kanter RJ, Garson A Jr. Atrial arrhythmias during chronic follow-up of surgery for complex congenital heart disease. Pacing Clin Electrophysiol 1997; 20:502.</a></li><li><a class="nounderline abstract_t">Bouchardy J, Therrien J, Pilote L, et al. Atrial arrhythmias in adults with congenital heart disease. Circulation 2009; 120:1679.</a></li><li><a class="nounderline abstract_t">Botto LD, Correa A, Erickson JD. Racial and temporal variations in the prevalence of heart defects. Pediatrics 2001; 107:E32.</a></li><li><a class="nounderline abstract_t">Walsh EP, Cecchin F. Arrhythmias in adult patients with congenital heart disease. Circulation 2007; 115:534.</a></li><li><a class="nounderline abstract_t">Murphy JG, Gersh BJ, McGoon MD, et al. Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years. N Engl J Med 1990; 323:1645.</a></li><li><a class="nounderline abstract_t">Roos-Hesselink J, Perlroth MG, McGhie J, Spitaels S. Atrial arrhythmias in adults after repair of tetralogy of Fallot. Correlations with clinical, exercise, and echocardiographic findings. Circulation 1995; 91:2214.</a></li><li><a class="nounderline abstract_t">Yap SC, Harris L, Chauhan VS, et al. Identifying high risk in adults with congenital heart disease and atrial arrhythmias. Am J Cardiol 2011; 108:723.</a></li><li><a class="nounderline abstract_t">Fishberger SB, Wernovsky G, Gentles TL, et al. Factors that influence the development of atrial flutter after the Fontan operation. J Thorac Cardiovasc Surg 1997; 113:80.</a></li><li><a class="nounderline abstract_t">Stephenson EA, Lu M, Berul CI, et al. Arrhythmias in a contemporary fontan cohort: prevalence and clinical associations in a multicenter cross-sectional study. J Am Coll Cardiol 2010; 56:890.</a></li><li><a class="nounderline abstract_t">Cecchin F, Johnsrude CL, Perry JC, Friedman RA. Effect of age and surgical technique on symptomatic arrhythmias after the Fontan procedure. Am J Cardiol 1995; 76:386.</a></li><li><a class="nounderline abstract_t">Stamm C, Friehs I, Mayer JE Jr, et al. Long-term results of the lateral tunnel Fontan operation. J Thorac Cardiovasc Surg 2001; 121:28.</a></li><li><a class="nounderline abstract_t">Walsh EP. Interventional electrophysiology in patients with congenital heart disease. Circulation 2007; 115:3224.</a></li><li><a class="nounderline abstract_t">Momma K, Takao A, Shibata T. Characteristics and natural history of abnormal atrial rhythms in left isomerism. Am J Cardiol 1990; 65:231.</a></li><li><a class="nounderline abstract_t">Anderson RH, Ho SY. The morphology of the specialized atrioventricular junctional area: the evolution of understanding. Pacing Clin Electrophysiol 2002; 25:957.</a></li><li><a class="nounderline abstract_t">Flinn CJ, Wolff GS, Dick M 2nd, et al. Cardiac rhythm after the Mustard operation for complete transposition of the great arteries. N Engl J Med 1984; 310:1635.</a></li><li><a class="nounderline abstract_t">Manning PB, Mayer JE Jr, Wernovsky G, et al. Staged operation to Fontan increases the incidence of sinoatrial node dysfunction. J Thorac Cardiovasc Surg 1996; 111:833.</a></li><li><a class="nounderline abstract_t">Weindling SN, Saul JP, Gamble WJ, et al. Duration of complete atrioventricular block after congenital heart disease surgery. Am J Cardiol 1998; 82:525.</a></li><li><a class="nounderline abstract_t">Bruckheimer E, Berul CI, Kopf GS, et al. Late recovery of surgically-induced atrioventricular block in patients with congenital heart disease. J Interv Card Electrophysiol 2002; 6:191.</a></li><li><a class="nounderline abstract_t">Allen MR, Hayes DL, Warnes CA, Danielson GK. Permanent pacing in Ebstein's anomaly. Pacing Clin Electrophysiol 1997; 20:1243.</a></li><li><a class="nounderline abstract_t">Cohen MI, Wernovsky G, Vetter VL, et al. Sinus node function after a systematically staged Fontan procedure. Circulation 1998; 98:II352.</a></li><li><a class="nounderline abstract_t">Graham TP Jr, Bernard YD, Mellen BG, et al. Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional study. J Am Coll Cardiol 2000; 36:255.</a></li><li><a class="nounderline abstract_t">Oliver JM, Gallego P, Gonzalez A, et al. Sinus venosus syndrome: atrial septal defect or anomalous venous connection? A multiplane transoesophageal approach. Heart 2002; 88:634.</a></li><li class="breakAll">Peacock, TB. Malformations of the heart. In: On Malformations of the Human Heart: With Original Cases, Peacock, TB (Eds), John Churchill, London 1858. p.11.</li><li><a class="nounderline abstract_t">Attenhofer Jost CH, Connolly HM, Danielson GK, et al. Sinus venosus atrial septal defect: long-term postoperative outcome for 115 patients. Circulation 2005; 112:1953.</a></li><li><a class="nounderline abstract_t">Anjos RT, Ho SY, Anderson RH. Surgical implications of juxtaposition of the atrial appendages. A review of forty-nine autopsied hearts. J Thorac Cardiovasc Surg 1990; 99:897.</a></li><li><a class="nounderline abstract_t">Ghai A, Harris L, Harrison DA, et al. Outcomes of late atrial tachyarrhythmias in adults after the Fontan operation. J Am Coll Cardiol 2001; 37:585.</a></li><li><a class="nounderline abstract_t">Jaeggi ET, Hamilton RM, Silverman ED, et al. Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. A single institution's experience of 30 years. J Am Coll Cardiol 2002; 39:130.</a></li><li><a class="nounderline abstract_t">Baruteau AE, Fouchard S, Behaghel A, et al. Characteristics and long-term outcome of non-immune isolated atrioventricular block diagnosed in utero or early childhood: a multicentre study. Eur Heart J 2012; 33:622.</a></li><li><a class="nounderline abstract_t">Anderson RH, Shinebourne EA, Gerlis LM. Criss-cross atrioventricular relationships producing paradoxical atrioventricular concordance or discordance. Their significance to nomenclature of congenital heart disease. Circulation 1974; 50:176.</a></li><li><a class="nounderline abstract_t">Connelly MS, Liu PP, Williams WG, et al. Congenitally corrected transposition of the great arteries in the adult: functional status and complications. J Am Coll Cardiol 1996; 27:1238.</a></li><li><a class="nounderline abstract_t">Li W, Somerville J. Atrial flutter in grown-up congenital heart (GUCH) patients. Clinical characteristics of affected population. Int J Cardiol 2000; 75:129.</a></li><li><a class="nounderline abstract_t">Wong T, Davlouros PA, Li W, et al. Mechano-electrical interaction late after Fontan operation: relation between P-wave duration and dispersion, right atrial size, and atrial arrhythmias. Circulation 2004; 109:2319.</a></li><li><a class="nounderline abstract_t">Haïssaguerre M, Jaïs P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339:659.</a></li><li><a class="nounderline abstract_t">Kirsh JA, Walsh EP, Triedman JK. Prevalence of and risk factors for atrial fibrillation and intra-atrial reentrant tachycardia among patients with congenital heart disease. Am J Cardiol 2002; 90:338.</a></li><li class="breakAll">Walsh, EP, Walsh, et al. Cardiac arrhythmias in children and young adults with congenital heart disease, Lippincott Williams &amp; Wilkins, Philadelphia 2001.</li><li><a class="nounderline abstract_t">Tracy CM, Swartz JF, Fletcher RD, et al. Radiofrequency catheter ablation of ectopic atrial tachycardia using paced activation sequence mapping. J Am Coll Cardiol 1993; 21:910.</a></li><li><a class="nounderline abstract_t">Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2019; 73:1494.</a></li><li><a class="nounderline abstract_t">Bhatt AB, Foster E, Kuehl K, et al. Congenital heart disease in the older adult: a scientific statement from the American Heart Association. Circulation 2015; 131:1884.</a></li><li><a class="nounderline abstract_t">Baumgartner H, De Backer J, Babu-Narayan SV, et al. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J 2021; 42:563.</a></li><li><a class="nounderline abstract_t">Akar JG, Kok LC, Haines DE, et al. Coexistence of type I atrial flutter and intra-atrial re-entrant tachycardia in patients with surgically corrected congenital heart disease. J Am Coll Cardiol 2001; 38:377.</a></li><li><a class="nounderline abstract_t">Park HE, Kim KH, Kim KB, et al. Characteristics of P wave in patients with sinus rhythm after maze operation. J Korean Med Sci 2010; 25:712.</a></li><li><a class="nounderline abstract_t">Dewey RC, Capeless MA, Levy AM. Use of ambulatory electrocardiographic monitoring to identify high-risk patients with congenital complete heart block. N Engl J Med 1987; 316:835.</a></li><li><a class="nounderline abstract_t">Khairy P, Van Hare GF, Balaji S, et al. PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Heart Rhythm 2014; 11:e102.</a></li><li><a class="nounderline abstract_t">Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347:1825.</a></li><li><a class="nounderline abstract_t">Opolski G, Torbicki A, Kosior DA, et al. Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study. Chest 2004; 126:476.</a></li><li><a class="nounderline abstract_t">Egbe AC, Asirvatham SJ, Connolly HM, et al. Outcomes of Direct Current Cardioversion in Adults With Congenital Heart Disease. Am J Cardiol 2017; 119:1468.</a></li><li><a class="nounderline abstract_t">Egbe AC, Connolly HM, Niaz T, McLeod CJ. Outcome of direct current cardioversion for atrial arrhythmia in adult Fontan patients. Int J Cardiol 2016; 208:115.</a></li><li><a class="nounderline abstract_t">Ammash NM, Phillips SD, Hodge DO, et al. Outcome of direct current cardioversion for atrial arrhythmias in adults with congenital heart disease. Int J Cardiol 2012; 154:270.</a></li><li><a class="nounderline abstract_t">Kusumoto FM, Schoenfeld MH, Barrett C, et al. 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2019; 74:e51.</a></li><li><a class="nounderline abstract_t">Khairy P, Landzberg MJ, Gatzoulis MA, et al. Transvenous pacing leads and systemic thromboemboli in patients with intracardiac shunts: a multicenter study. Circulation 2006; 113:2391.</a></li><li><a class="nounderline abstract_t">Cohen MI, Bush DM, Vetter VL, et al. Permanent epicardial pacing in pediatric patients: seventeen years of experience and 1200 outpatient visits. Circulation 2001; 103:2585.</a></li><li><a class="nounderline abstract_t">Odim J, Suckow B, Saedi B, et al. Equivalent performance of epicardial versus endocardial permanent pacing in children: a single institution and manufacturer experience. Ann Thorac Surg 2008; 85:1412.</a></li><li><a class="nounderline abstract_t">Noheria A, van Zyl M, Scott LR, et al. Single-site ventricular pacing via the coronary sinus in patients with tricuspid valve disease. Europace 2018; 20:636.</a></li><li><a class="nounderline abstract_t">Perry JC, Garson A Jr. Flecainide acetate for treatment of tachyarrhythmias in children: review of world literature on efficacy, safety, and dosing. Am Heart J 1992; 124:1614.</a></li><li><a class="nounderline abstract_t">Pfammatter JP, Paul T, Lehmann C, Kallfelz HC. Efficacy and proarrhythmia of oral sotalol in pediatric patients. J Am Coll Cardiol 1995; 26:1002.</a></li><li><a class="nounderline abstract_t">Anastasiou-Nana MI, Anderson JL, Stewart JR, et al. Occurrence of exercise-induced and spontaneous wide complex tachycardia during therapy with flecainide for complex ventricular arrhythmias: a probable proarrhythmic effect. Am Heart J 1987; 113:1071.</a></li><li><a class="nounderline abstract_t">Wells R, Khairy P, Harris L, et al. Dofetilide for atrial arrhythmias in congenital heart disease: a multicenter study. Pacing Clin Electrophysiol 2009; 32:1313.</a></li><li><a class="nounderline abstract_t">Moore BM, Cordina RL, McGuire MA, Celermajer DS. Efficacy and adverse effects of sotalol in adults with congenital heart disease. Int J Cardiol 2019; 274:74.</a></li><li><a class="nounderline abstract_t">Miyazaki A, Ohuchi H, Kurosaki K, et al. Efficacy and safety of sotalol for refractory tachyarrhythmias in congenital heart disease. Circ J 2008; 72:1998.</a></li><li><a class="nounderline abstract_t">Moore BM, Cordina RL, McGuire MA, Celermajer DS. Adverse effects of amiodarone therapy in adults with congenital heart disease. Congenit Heart Dis 2018; 13:944.</a></li><li><a class="nounderline abstract_t">Thorne SA, Barnes I, Cullinan P, Somerville J. Amiodarone-associated thyroid dysfunction: risk factors in adults with congenital heart disease. Circulation 1999; 100:149.</a></li><li><a class="nounderline abstract_t">Kanter RJ, Papagiannis J, Carboni MP, et al. Radiofrequency catheter ablation of supraventricular tachycardia substrates after mustard and senning operations for d-transposition of the great arteries. J Am Coll Cardiol 2000; 35:428.</a></li><li><a class="nounderline abstract_t">Egbe AC, Connolly HM, Khan AR, et al. Outcomes in adult Fontan patients with atrial tachyarrhythmias. Am Heart J 2017; 186:12.</a></li><li><a class="nounderline abstract_t">de Groot NM, Atary JZ, Blom NA, Schalij MJ. Long-term outcome after ablative therapy of postoperative atrial tachyarrhythmia in patients with congenital heart disease and characteristics of atrial tachyarrhythmia recurrences. Circ Arrhythm Electrophysiol 2010; 3:148.</a></li><li><a class="nounderline abstract_t">Triedman JK, Alexander ME, Love BA, et al. Influence of patient factors and ablative technologies on outcomes of radiofrequency ablation of intra-atrial re-entrant tachycardia in patients with congenital heart disease. J Am Coll Cardiol 2002; 39:1827.</a></li><li><a class="nounderline abstract_t">Jaïs P, Shah DC, Haïssaguerre M, et al. Prospective randomized comparison of irrigated-tip versus conventional-tip catheters for ablation of common flutter. Circulation 2000; 101:772.</a></li><li><a class="nounderline abstract_t">Triedman JK, DeLucca JM, Alexander ME, et al. Prospective trial of electroanatomically guided, irrigated catheter ablation of atrial tachycardia in patients with congenital heart disease. Heart Rhythm 2005; 2:700.</a></li><li><a class="nounderline abstract_t">Yap SC, Harris L, Silversides CK, et al. Outcome of intra-atrial re-entrant tachycardia catheter ablation in adults with congenital heart disease: negative impact of age and complex atrial surgery. J Am Coll Cardiol 2010; 56:1589.</a></li><li><a class="nounderline abstract_t">Rhodes LA, Walsh EP, Gamble WJ, et al. Benefits and potential risks of atrial antitachycardia pacing after repair of congenital heart disease. Pacing Clin Electrophysiol 1995; 18:1005.</a></li><li><a class="nounderline abstract_t">Stephenson EA, Casavant D, Tuzi J, et al. Efficacy of atrial antitachycardia pacing using the Medtronic AT500 pacemaker in patients with congenital heart disease. Am J Cardiol 2003; 92:871.</a></li><li><a class="nounderline abstract_t">Fuster V, Rydén LE, Cannom DS, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114:e257.</a></li><li><a class="nounderline abstract_t">Stulak JM, Dearani JA, Sundt TM 3rd, et al. Superiority of cut-and-sew technique for the Cox maze procedure: comparison with radiofrequency ablation. J Thorac Cardiovasc Surg 2007; 133:1022.</a></li><li><a class="nounderline abstract_t">Stulak JM, Dearani JA, Puga FJ, et al. Right-sided Maze procedure for atrial tachyarrhythmias in congenital heart disease. Ann Thorac Surg 2006; 81:1780.</a></li><li><a class="nounderline abstract_t">Egbe AC, Connolly HM, McLeod CJ, et al. Thrombotic and Embolic Complications Associated With Atrial Arrhythmia After Fontan Operation: Role of Prophylactic Therapy. J Am Coll Cardiol 2016; 68:1312.</a></li><li><a class="nounderline abstract_t">Yang H, Bouma BJ, Dimopoulos K, et al. Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study. Int J Cardiol 2020; 299:123.</a></li><li><a class="nounderline abstract_t">Pujol C, Müssigmann M, Schiele S, et al. Direct oral anticoagulants in adults with congenital heart disease - a single centre study. Int J Cardiol 2020; 300:127.</a></li><li><a class="nounderline abstract_t">Kawamatsu N, Ishizu T, Machino-Ohtsuka T, et al. Direct oral anticoagulant use and outcomes in adult patients with Fontan circulation: A multicenter retrospective cohort study. Int J Cardiol 2021; 327:74.</a></li><li><a class="nounderline abstract_t">Kalman JM, VanHare GF, Olgin JE, et al. Ablation of 'incisional' reentrant atrial tachycardia complicating surgery for congenital heart disease. Use of entrainment to define a critical isthmus of conduction. Circulation 1996; 93:502.</a></li><li><a class="nounderline abstract_t">Mavroudis C, Deal BJ, Backer CL, Tsao S. Arrhythmia surgery in patients with and without congenital heart disease. Ann Thorac Surg 2008; 86:857.</a></li><li><a class="nounderline abstract_t">Drago F, Silvetti MS, Grutter G, De Santis A. Long term management of atrial arrhythmias in young patients with sick sinus syndrome undergoing early operation to correct congenital heart disease. Europace 2006; 8:488.</a></li><li><a class="nounderline abstract_t">Khairy P, Aboulhosn J, Gurvitz MZ, et al. Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study. Circulation 2010; 122:868.</a></li><li><a class="nounderline abstract_t">Gelatt M, Hamilton RM, McCrindle BW, et al. Risk factors for atrial tachyarrhythmias after the Fontan operation. J Am Coll Cardiol 1994; 24:1735.</a></li><li><a class="nounderline abstract_t">Deshaies C, Hamilton RM, Shohoudi A, et al. Thromboembolic Risk After Atriopulmonary, Lateral Tunnel, and Extracardiac Conduit Fontan Surgery. J Am Coll Cardiol 2019; 74:1071.</a></li><li><a class="nounderline abstract_t">Quinton E, Nightingale P, Hudsmith L, et al. Prevalence of atrial tachyarrhythmia in adults after Fontan operation. Heart 2015; 101:1672.</a></li><li><a class="nounderline abstract_t">Mavroudis C, Backer CL, Deal BJ. Late reoperations for Fontan patients: state of the art invited review. Eur J Cardiothorac Surg 2008; 34:1034.</a></li><li><a class="nounderline abstract_t">Takahashi K, Cecchin F, Fortescue E, et al. Permanent atrial pacing lead implant route after Fontan operation. Pacing Clin Electrophysiol 2009; 32:779.</a></li></ol></div><div id="topicVersionRevision">Topic 13599 Version 24.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17210844" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Congenital heart disease in the general population: changing prevalence and age distribution.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10655533" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Congenital heart disease in adults. Second of two parts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10648769" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Congenital heart disease in adults. First of two parts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27382105" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Congenital Heart Defects in the United States: Estimating the Magnitude of the Affected Population in 2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12084585" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : The incidence of congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30712848" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Atrial fibrillation in adults with congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15996978" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. The Euro Heart Survey on adult congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9058852" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Atrial arrhythmias during chronic follow-up of surgery for complex congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19822808" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Atrial arrhythmias in adults with congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11230613" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Racial and temporal variations in the prevalence of heart defects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17261672" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Arrhythmias in adult patients with congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2233961" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7697851" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Atrial arrhythmias in adults after repair of tetralogy of Fallot. Correlations with clinical, exercise, and echocardiographic findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21684512" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Identifying high risk in adults with congenital heart disease and atrial arrhythmias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9011705" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Factors that influence the development of atrial flutter after the Fontan operation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20813285" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Arrhythmias in a contemporary fontan cohort: prevalence and clinical associations in a multicenter cross-sectional study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7639165" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Effect of age and surgical technique on symptomatic arrhythmias after the Fontan procedure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11135157" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Long-term results of the lateral tunnel Fontan operation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17592091" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Interventional electrophysiology in patients with congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2296892" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Characteristics and natural history of abnormal atrial rhythms in left isomerism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12137349" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : The morphology of the specialized atrioventricular junctional area: the evolution of understanding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6727935" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Cardiac rhythm after the Mustard operation for complete transposition of the great arteries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8614144" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Staged operation to Fontan increases the incidence of sinoatrial node dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9723647" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Duration of complete atrioventricular block after congenital heart disease surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11992032" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Late recovery of surgically-induced atrioventricular block in patients with congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9170123" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Permanent pacing in Ebstein's anomaly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9852926" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Sinus node function after a systematically staged Fontan procedure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10898443" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12433899" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Sinus venosus syndrome: atrial septal defect or anomalous venous connection? A multiplane transoesophageal approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12433899" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Sinus venosus syndrome: atrial septal defect or anomalous venous connection? A multiplane transoesophageal approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16172274" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Sinus venosus atrial septal defect: long-term postoperative outcome for 115 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2329829" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Surgical implications of juxtaposition of the atrial appendages. A review of forty-nine autopsied hearts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11216983" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Outcomes of late atrial tachyarrhythmias in adults after the Fontan operation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11755298" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. A single institution's experience of 30 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21920962" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Characteristics and long-term outcome of non-immune isolated atrioventricular block diagnosed in utero or early childhood: a multicentre study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4835263" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Criss-cross atrioventricular relationships producing paradoxical atrioventricular concordance or discordance. Their significance to nomenclature of congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8609349" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Congenitally corrected transposition of the great arteries in the adult: functional status and complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11077123" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Atrial flutter in grown-up congenital heart (GUCH) patients. Clinical characteristics of affected population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15136502" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Mechano-electrical interaction late after Fontan operation: relation between P-wave duration and dispersion, right atrial size, and atrial arrhythmias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9725923" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12127629" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Prevalence of and risk factors for atrial fibrillation and intra-atrial reentrant tachycardia among patients with congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12127629" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Prevalence of and risk factors for atrial fibrillation and intra-atrial reentrant tachycardia among patients with congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8450159" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Radiofrequency catheter ablation of ectopic atrial tachycardia using paced activation sequence mapping.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30121240" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25896865" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Congenital heart disease in the older adult: a scientific statement from the American Heart Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32860028" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : 2020 ESC Guidelines for the management of adult congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11499727" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Coexistence of type I atrial flutter and intra-atrial re-entrant tachycardia in patients with surgically corrected congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20436706" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Characteristics of P wave in patients with sinus rhythm after maze operation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3821827" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Use of ambulatory electrocardiographic monitoring to identify high-risk patients with congenital complete heart block.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24814377" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12466506" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : A comparison of rate control and rhythm control in patients with atrial fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15302734" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28262200" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Outcomes of Direct Current Cardioversion in Adults With Congenital Heart Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26849685" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Outcome of direct current cardioversion for atrial arrhythmia in adult Fontan patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20934227" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Outcome of direct current cardioversion for atrial arrhythmias in adults with congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30412709" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16702467" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Transvenous pacing leads and systemic thromboemboli in patients with intracardiac shunts: a multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11382728" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Permanent epicardial pacing in pediatric patients: seventeen years of experience and 1200 outpatient visits.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18355537" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Equivalent performance of epicardial versus endocardial permanent pacing in children: a single institution and manufacturer experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28339945" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Single-site ventricular pacing via the coronary sinus in patients with tricuspid valve disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1462922" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Flecainide acetate for treatment of tachyarrhythmias in children: review of world literature on efficacy, safety, and dosing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7560592" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Efficacy and proarrhythmia of oral sotalol in pediatric patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3107362" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Occurrence of exercise-induced and spontaneous wide complex tachycardia during therapy with flecainide for complex ventricular arrhythmias: a probable proarrhythmic effect.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19691680" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Dofetilide for atrial arrhythmias in congenital heart disease: a multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29954667" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Efficacy and adverse effects of sotalol in adults with congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18931451" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Efficacy and safety of sotalol for refractory tachyarrhythmias in congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30239160" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Adverse effects of amiodarone therapy in adults with congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10402444" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Amiodarone-associated thyroid dysfunction: risk factors in adults with congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10676691" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Radiofrequency catheter ablation of supraventricular tachycardia substrates after mustard and senning operations for d-transposition of the great arteries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28454826" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Outcomes in adult Fontan patients with atrial tachyarrhythmias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20194797" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Long-term outcome after ablative therapy of postoperative atrial tachyarrhythmia in patients with congenital heart disease and characteristics of atrial tachyarrhythmia recurrences.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12039499" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Influence of patient factors and ablative technologies on outcomes of radiofrequency ablation of intra-atrial re-entrant tachycardia in patients with congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10683351" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Prospective randomized comparison of irrigated-tip versus conventional-tip catheters for ablation of common flutter.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15992724" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Prospective trial of electroanatomically guided, irrigated catheter ablation of atrial tachycardia in patients with congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21029876" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Outcome of intra-atrial re-entrant tachycardia catheter ablation in adults with congenital heart disease: negative impact of age and complex atrial surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7659551" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Benefits and potential risks of atrial antitachycardia pacing after repair of congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14516898" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Efficacy of atrial antitachycardia pacing using the Medtronic AT500 pacemaker in patients with congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16908781" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17382646" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Superiority of cut-and-sew technique for the Cox maze procedure: comparison with radiofrequency ablation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16631672" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Right-sided Maze procedure for atrial tachyarrhythmias in congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27634123" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Thrombotic and Embolic Complications Associated With Atrial Arrhythmia After Fontan Operation: Role of Prophylactic Therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31307847" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31668654" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Direct oral anticoagulants in adults with congenital heart disease - a single centre study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33220361" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Direct oral anticoagulant use and outcomes in adult patients with Fontan circulation: A multicenter retrospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8565168" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Ablation of 'incisional' reentrant atrial tachycardia complicating surgery for congenital heart disease. Use of entrainment to define a critical isthmus of conduction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18721574" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Arrhythmia surgery in patients with and without congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16798761" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Long term management of atrial arrhythmias in young patients with sick sinus syndrome undergoing early operation to correct congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20713900" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7963122" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Risk factors for atrial tachyarrhythmias after the Fontan operation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31439217" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Thromboembolic Risk After Atriopulmonary, Lateral Tunnel, and Extracardiac Conduit Fontan Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26289423" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Prevalence of atrial tachyarrhythmia in adults after Fontan operation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18977665" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Late reoperations for Fontan patients: state of the art invited review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19545341" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Permanent atrial pacing lead implant route after Fontan operation.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
